Cargando…
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer
BACKGROUND: The incidence of colorectal cancer (CRC) is considered to be the third-highest malignant tumor among all carcinomas. The alterations in cellular bioenergetics (metabolic reprogramming) are associated with several malignant phenotypes in CRC, such as tumor cell proliferation, invasion, me...
Autores principales: | Liu, Jiaxin, Li, Yimin, Xiao, Qing, Li, Yuanyuan, Peng, Yuqian, Gan, Yaqi, Shu, Guang, Yi, Hanxi, Yin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531485/ https://www.ncbi.nlm.nih.gov/pubmed/36195841 http://dx.doi.org/10.1186/s12885-022-10126-0 |
Ejemplares similares
-
Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021) -
CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
por: Gan, Yaqi, et al.
Publicado: (2018) -
EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer
por: Li, Yimin, et al.
Publicado: (2020) -
Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer
por: Li, Yimin, et al.
Publicado: (2022) -
MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression
por: Xiao, Qing, et al.
Publicado: (2021)